Rare diseases
Investigational molecules
Locations
Study on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis
PolandStudy on Basimglurant for Treating Pain in Patients with Trigeminal Neuralgia
PolandStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
PolandStudy on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis
PolandStudy on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
PolandEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
PolandStudy of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer
PolandWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
PolandGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
PolandA Phase 2 Study of JNJ-79635322 in Patients with Relapsed or Refractory Multiple Myeloma
PolandLong‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study
PolandTulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
